APA (7th ed.) Citation

JR, P., WD, H., JW, H., CP, R., A, C., CJ, K., . . . CE, S. (2022). Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. NPJ Parkinson's disease, 8(1), 61. https://doi.org/10.1038/s41531-022-00322-x

Chicago Style (17th ed.) Citation

JR, Patterson, et al. "Beta2-adrenoreceptor Agonist Clenbuterol Produces Transient Decreases in Alpha-synuclein MRNA but No Long-term Reduction in Protein." NPJ Parkinson's Disease 8, no. 1 (2022): 61. https://doi.org/10.1038/s41531-022-00322-x.

MLA (9th ed.) Citation

JR, Patterson, et al. "Beta2-adrenoreceptor Agonist Clenbuterol Produces Transient Decreases in Alpha-synuclein MRNA but No Long-term Reduction in Protein." NPJ Parkinson's Disease, vol. 8, no. 1, 2022, p. 61, https://doi.org/10.1038/s41531-022-00322-x.